Evidence for the Universal Blood Pressure Goal of <130/80 mm Hg Is Strong: Controversies in Hypertension - Pro Side of the Argument

doi:10.1161/HYPERTENSIONAHA.120.14647

Review

. 2020 Nov;76(5):1384-1390.

doi: 10.1161/HYPERTENSIONAHA.120.14647. Epub 2020 Sep 21.

Evidence for the Universal Blood Pressure Goal of <130/80 mm Hg Is Strong: Controversies in Hypertension - Pro Side of the Argument

Robert M Carey¹, Paul K Whelton²

Affiliations

¹ From the Department of Medicine, University of Virginia Health System, Charlottesville, VA (R.M.C.).
² Departments of Epidemiology and Medicine, Tulane University, New Orleans, LA (P.K.W.).

PMID: 32951472
PMCID: PMC8279218
DOI: 10.1161/HYPERTENSIONAHA.120.14647

Review

Evidence for the Universal Blood Pressure Goal of <130/80 mm Hg Is Strong: Controversies in Hypertension - Pro Side of the Argument

Robert M Carey et al. Hypertension. 2020 Nov.

. 2020 Nov;76(5):1384-1390.

doi: 10.1161/HYPERTENSIONAHA.120.14647. Epub 2020 Sep 21.

Authors

Robert M Carey¹, Paul K Whelton²

Affiliations

¹ From the Department of Medicine, University of Virginia Health System, Charlottesville, VA (R.M.C.).
² Departments of Epidemiology and Medicine, Tulane University, New Orleans, LA (P.K.W.).

PMID: 32951472
PMCID: PMC8279218
DOI: 10.1161/HYPERTENSIONAHA.120.14647

No abstract available

PubMed Disclaimer

Cited by

Guideline-Driven Management of Hypertension: An Evidence-Based Update.
Carey RM, Wright JT Jr, Taler SJ, Whelton PK. Carey RM, et al. Circ Res. 2021 Apr 2;128(7):827-846. doi: 10.1161/CIRCRESAHA.121.318083. Epub 2021 Apr 1. Circ Res. 2021. PMID: 33793326 Free PMC article. Review.
Blood pressure targets for the treatment of people with hypertension and cardiovascular disease.
Saiz LC, Gorricho J, Garjón J, Celaya MC, Erviti J, Leache L. Saiz LC, et al. Cochrane Database Syst Rev. 2022 Nov 18;11(11):CD010315. doi: 10.1002/14651858.CD010315.pub5. Cochrane Database Syst Rev. 2022. PMID: 36398903 Free PMC article.
Design and rationale for a randomized, open-label, parallel clinical trial evaluating major adverse cardiovascular events (pharmacological treatment versus diet control) in patients with high-normal blood pressure: the PRINT-TAHA9 trial.
Attar A, Mirhosseini SA, Borazjani R, Sayadi M, Ahadi M, Zibaeenezhad M, Razeghian-Jahromi I, Parsa N. Attar A, et al. Trials. 2024 Aug 26;25(1):563. doi: 10.1186/s13063-024-08420-2. Trials. 2024. PMID: 39187881 Free PMC article. Clinical Trial.
Association of blood pressure and long-term change with chronic kidney disease risk among Chinese adults with different glucose metabolism according to the 2017 ACC/AHA guidelines.
He J, Li Z, Wang R, Nie H, Wang F, Yuan J, Miao X, Yao P, Wei S, Zhang X, Guo H, Yang H, Wu T, He M. He J, et al. J Clin Hypertens (Greenwich). 2021 Dec;23(12):2080-2088. doi: 10.1111/jch.14371. Epub 2021 Nov 12. J Clin Hypertens (Greenwich). 2021. PMID: 34773360 Free PMC article.
Hypertension Management in Peripheral Artery Disease: A Mini Review.
Kharawala A, Nagraj S, Pargaonkar S, Seo J, Kokkinidis DG, Altin SE. Kharawala A, et al. Curr Hypertens Rev. 2024;20(1):1-9. doi: 10.2174/0115734021267004231122061712. Curr Hypertens Rev. 2024. PMID: 38083897 Review.

See all "Cited by" articles

References

1. Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and control of hypertension. JACC Health Promotion Series. J Am Coll Cardiol. 2018;72:1278–1293. - PMC - PubMed
1. The US Burden of Disease Collaborators. The state of US health 1990–2016: burden of disease, injuries and risk factors among US states. JAMA. 2018;319:1444–1472. - PMC - PubMed
1. GBD 2016 Risk Factors Collaborators. Global, regional and national comparative risk assessment of 84 behavioral, environmental, occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2016;390:1345–1422. - PMC - PubMed
1. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913. - PubMed
1. Blood Pressure Lowering Treatment Trialists’ Collaboration. Effect s of different blood pressure lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomized trials. Lancet. 2003;362:1527–1535. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

[1] Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and control of hypertension. JACC Health Promotion Series. J Am Coll Cardiol. 2018;72:1278–1293. - PMC - PubMed

[2] Carey RM, Muntner P, Bosworth HB, Whelton PK. Prevention and control of hypertension. JACC Health Promotion Series. J Am Coll Cardiol. 2018;72:1278–1293. - PMC - PubMed

[3] The US Burden of Disease Collaborators. The state of US health 1990–2016: burden of disease, injuries and risk factors among US states. JAMA. 2018;319:1444–1472. - PMC - PubMed

[4] The US Burden of Disease Collaborators. The state of US health 1990–2016: burden of disease, injuries and risk factors among US states. JAMA. 2018;319:1444–1472. - PMC - PubMed

[5] GBD 2016 Risk Factors Collaborators. Global, regional and national comparative risk assessment of 84 behavioral, environmental, occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2016;390:1345–1422. - PMC - PubMed

[6] GBD 2016 Risk Factors Collaborators. Global, regional and national comparative risk assessment of 84 behavioral, environmental, occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2016;390:1345–1422. - PMC - PubMed

[7] Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913. - PubMed

[8] Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913. - PubMed

[9] Blood Pressure Lowering Treatment Trialists’ Collaboration. Effect s of different blood pressure lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomized trials. Lancet. 2003;362:1527–1535. - PubMed

[10] Blood Pressure Lowering Treatment Trialists’ Collaboration. Effect s of different blood pressure lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomized trials. Lancet. 2003;362:1527–1535. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Evidence for the Universal Blood Pressure Goal of <130/80 mm Hg Is Strong: Controversies in Hypertension - Pro Side of the Argument

Affiliations

Evidence for the Universal Blood Pressure Goal of <130/80 mm Hg Is Strong: Controversies in Hypertension - Pro Side of the Argument

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical